Yan Li, PhD's Publications

Advanced Hyperpolarized 13C Metabolic Imaging Protocol for Patients with Gliomas: A Comprehensive Multimodal MRI Approach.

Improving the Generalizability of Deep Learning for T2-Lesion Segmentation of Gliomas in the Post-Treatment Setting.

Atlas-Based Adaptive Hadamard-Encoded MR Spectroscopic Imaging at 3T.

Evaluation of deep learning models for quality control of MR spectra.

Evaluation of major depressive disorder using 7 Tesla phase sensitive neuroimaging before and after mindfulness-based cognitive therapy.

Hyperpolarized [2-13C]pyruvate MR molecular imaging with whole brain coverage.

Investigating cerebral perfusion with high resolution hyperpolarized [1-13 C]pyruvate MRI.

Multi-parametric hyperpolarized 13C/1H imaging reveals Warburg-related metabolic dysfunction and associated regional heterogeneity in high-grade human gliomas.

Protocol for teen inflammation glutamate emotion research (TIGER): Toward predictors of treatment response and clinical course in depressed adolescents.

Assessment of higher-order singular value decomposition denoising methods on dynamic hyperpolarized [1-13C]pyruvate MRI data from patients with glioma.

Kinetic analysis of multi-resolution hyperpolarized 13 C human brain MRI to study cerebral metabolism.

Longitudinal MR spectroscopy to detect progression in patients with lower-grade glioma in the surveillance phase.

Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas.

Current human brain applications and challenges of dynamic hyperpolarized carbon-13 labeled pyruvate MR metabolic imaging.

Denoising of hyperpolarized 13 C MR images of the human brain using patch-based higher-order singular value decomposition.

Shimming-the forgotten child of in-vivo MR?

A variable resolution approach for improved acquisition of hyperpolarized 13 C metabolic MRI.

C-13 Hyperpolarized MR Spectroscopy for Metabolic Imaging of Brain Tumors.

Characterization of serial hyperpolarized 13C metabolic imaging in patients with glioma.

Hyperpolarized 13 C MRI data acquisition and analysis in prostate and brain at University of California, San Francisco.

Pilot Study of Hyperpolarized 13C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers.

Tensor image enhancement and optimal multichannel receiver combination analyses for human hyperpolarized 13 C MRSI.

Coil combination methods for multi-channel hyperpolarized 13C imaging data from human studies.

Comparison between 8- and 32-channel phased-array receive coils for in vivo hyperpolarized 13 C imaging of the human brain.

First hyperpolarized [2-13C]pyruvate MR studies of human brain metabolism.

Kinetic Modeling of Hyperpolarized Carbon-13 Pyruvate Metabolism in the Human Brain.

Quantitative MRI of the Brain: Principles of Physical Measurement (by Mara Cercignani, Nicholas G. Dowell, Paul S. Tofts)

Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR.

Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients.

Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen.

Comparison between Short and Long Echo Time Magnetic Resonance Spectroscopic Imaging at 3T and 7T for Evaluating Brain Metabolites in Patients with Glioma.

Fully automated atlas-based method for prescribing 3D PRESS MR spectroscopic imaging: Toward robust and reproducible metabolite measurements in human brain.

Reliable and Reproducible GABA Measurements Using Automated Spectral Prescription at Ultra-High Field.

Evaluating metabolites in patients with major depressive disorder who received mindfulness-based cognitive therapy and healthy controls using short echo MRSI at 7 Tesla.

NIMG-32. 3D SHORT AND LONG ECHO TIME 1H MRSI IN PATIENTS WITH NON-ENHANCING GLIOMAS.

NIMG-65. IN VIVO DETECTION OF 2-HYDROXYGLUTARATE IN LOW-GRADE IDH-MUTANT GLIOMAS WITH STABLE DISEASE.

Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab.

Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials.

Imaging tumor metabolism using in vivo magnetic resonance spectroscopy.

Short-echo three-dimensional H-1 MR spectroscopic imaging of patients with glioma at 7 Tesla for characterization of differences in metabolite levels.

Strategies for rapid in vivo 1H and hyperpolarized 13C MR spectroscopic imaging.

Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging.

Advances in ultra-high field MRI for the clinical management of patients with brain tumors.

Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme.

Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T.

Phased array 3D MR spectroscopic imaging of the brain at 7 T.

Three-dimensional J-resolved H-1 magnetic resonance spectroscopic imaging of volunteers and patients with brain tumors at 3T.

Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T.